The Impact of Fish Oil Supplementation on the Outcome of Children With Pneumonia i
- Conditions
- Pneumonia
- Interventions
- Dietary Supplement: Fish oil (Omega)
- Registration Number
- NCT06005454
- Lead Sponsor
- Cairo University
- Brief Summary
The aim of study is to investigate the effect of enteral feeding of Omega-3 on the outcome of children with Pneumonia in PICU
- Detailed Description
Group A(cases) will be supplemented by omega-3 fatty acids for immediate post admission consecutive 7 days besides conventional treatment of pneumonia, in a dose of 350 mg twice daily for children less than 3 years and 450 mg twice daily for older children according to the standard treatment per the American Institute of Medicine of the National Academies guidelines for maximum dose for this age group. (Institute of Medicine of the National Academies,2016)
Side effects of omega-3 supplements are usually mild. They include unpleasant taste, bad breath, bad-smelling sweat, headache, and gastrointestinal symptoms such as heartburn, nausea, and diarrhea. (Office of Dietary Supplements ,2016)
Group B(controls) will be received enteral feeding without omega-3 fatty acid support.
Recruitment & Eligibility
- Status
- COMPLETED
- Sex
- All
- Target Recruitment
- 122
Not provided
Not provided
Study & Design
- Study Type
- INTERVENTIONAL
- Study Design
- PARALLEL
- Arm && Interventions
Group Intervention Description Children with Pneumonia in intensive care unit receiving fish oil and the standard treatment Fish oil (Omega) -
- Primary Outcome Measures
Name Time Method Hospital length stay Through study completion, an average of 1 yea Hospital length stay will be measured between the two groups
- Secondary Outcome Measures
Name Time Method
Trial Locations
- Locations (1)
Hoda Atef Abdelsattar Ibrahim
🇪🇬Cairo, Egypt